Therapeutic Development Suppliers Serving Europe

AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...

Advancing an integrated pipeline of genetic therapies that correct the root cause of complex and rare life-threatening childhood disorders. Our mission is to develop first-in-class and best-in-class, curative gene therapies for patients with ...

In 2019, ProMedDx and GLAS Bio were acquired by Precision for Medicine, part of Precision Medicine Group. This new combination significantly bolstered the selection, scientific prowess and solutions available to customers from a single partner. With ...

Cerus Endovascular is a privately owned medical device company based in Fremont, California and Oxford, United Kingdom. We design, develop, manufacture and supply Neurovascular products used by Interventional Neuroradiologists for the treatment of ...

We are a specialized pharmaceutical company engaged in the research, development, manufacture and marketing of pharmaceutical products. Our operations encompass the marketing of both our own and licensed products and the provision of services, such ...

Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health. Based on a foundation of engineering and chemistry, Synthego leverages automation and machine ...

Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...

Anaerobe Systems produces the world’s only true pre-reduced anaerobically sterilized (PRAS) culture media: poured and packaged under anaerobic conditions. Founded over 40 years ago, for scientists by scientists, Anaerobe Systems has discovered ...

Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation ...

We develop and commercialize patented, disruptive liquid biopsy tests – innovative blood tests in oncology – based on a unique cell isolation technology called ISET (Isolation by SizE of Tumor cells) and cyto-molecular profiling of Circulating Tumor ...

The American Statistical Association is the world’s largest community of statisticians, the “Big Tent for Statistics.” It is the second-oldest, continuously operating professional association in the country. Since it was founded in Boston in 1839, ...

As the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world, we conduct all our business responsibly and with integrity. Our ...

Molteni Therapeutics is an Italian product-driven spin-off company of Molteni Farmaceutici a private–owned pharmaceutical firm based in Florence since 1892, dedicated to the development of innovative Medical Devices mainly based on the Photo Dynamic ...

Since 1983 we have been working to become the international landmark in lasertherapy and magnetotherapy for multidisciplinary use: from physiotherapy to rehabilitation, from pain management – both muscular and articular - to sports medicine and ...

Curadigm is an early-stage company focused on shifting the paradigm of therapeutic clearance, bioavailability, and efficacy to improve treatment outcomes for millions of patients. Curadigm was spun-off from Nanobiotix, a late-stage clinical company, ...

Aviva Systems Biology provides our customers with an extensive collection of quality antibodies for research and diagnostic applications. Aviva currently offers antibodies to more than 7,000 different protein targets due to our high throughput ...

Aposcience AG is a worldwide innovation leader in the field of regenerative medicine. Regenerative medicine has the potential to transform the treatment for diseases with high medical need, as the tissues afflicted by the disease process can be ...

Multiomic Health Limited is a next-generation precision medicine business, applying computational systems biology to develop and commercialize data assets for metabolic syndrome. Multiomic is a next-generation precision medicine business, applying ...

We are an investigational-stage infectious disease company focused on combating all diseases resulting from herpes simplex virus 1 (HSV-1) and herpes simplex virus 2 (HSV-2) infections. Using our proprietary technology, we are developing rationally ...

Vivesto AB is a specialty pharmaceutical company focused on thedevelopment of new therapeutic options for patients suffering from hard-to-treatcancers. It has an emerging pipeline of clinical-stage assets targeting late-stagecancers. Apealea® ...